Industrial, Manufacturing & Heavy Industry Market News

Fluoroscopy equipment market worth 2.79 billion USD by 2022 according to new research report

Fluoroscopy equipment market worth 2.79 billion USD by 2022 according to new research report

According to a new market research report "Fluoroscopy Equipment Market by Product (Fixed Fluoroscopy Equipment (Remote Controlled, Conventional), C-arms), Application (Diagnostic (Cardiology, Gastroenterology), Surgical (Orthopedic, Cardiovascular)) and Region - Global Forecast to 2022", published by MarketsandMarkets™, the market is projected to reach USD 2.79 Billion by 2022 from USD 2.21 Billion in 2017, at a CAGR of 4.8% during the forecast period.

- Advertising -

Browse 65 Market Data Tables and 39 Figures spread through 141 Pages and in-depth TOC on "Fluoroscopy Equipment Market"

www.marketsandmarkets.com/Market-R…m_campaign=PaidPR

By product, the fixed fluoroscopy segment accounted for the largest share of the market in 2017 

On the basis of product, the Fluoroscopy Equipment Market is broadly segmented into fixed fluoroscopy equipment and C-arms. In 2017, the fixed fluoroscopy equipment segment is expected to account for the largest share of this market owing to the increasing use of fluoroscopy in diagnostic imaging across various application areas like cardiology, gastroenterology, and urology.

The fixed fluoroscopy equipment segment is further segmented into remote-controlled fluoroscopy systems and conventional fluoroscopy systems. The remote-controlled fluoroscopy systems segment accounted for the largest share and highest CAGR of the fixed Fluoroscopy Equipment Market in 2016.

- Advertising -

Download PDF Brochure: www.marketsandmarkets.com/pdfdownl…m_campaign=PaidPR

By application, the diagnostic application segment held the largest market share in 2017 

Based on application, the market is segmented into diagnostic applications and surgical applications. The diagnostic applications segment is further segmented into cardiology, gastroenterology, urology & nephrology, and other diagnostic applications (orthopedics, neurology, and gynecology).

The cardiology segment is estimated to command the largest share of the Fluoroscopy Equipment Market for diagnostic applications. The large share and high growth of this segment can be attributed to the rising geriatric population, increasing prevalence of cardiovascular diseases (CVDs), and the wide use of fluoroscopic imaging in the diagnosis and treatment of various cardiac conditions.

North America dominated the market in 2017 

North America accounted for the largest share of the Fluoroscopy Equipment Market in 2017, followed by Europe, Asia Pacific(APAC) and the Rest of the World (Latin America and the Middle East and Africa). Factors such as increasing incidence of overuse sports injuries, rising prevalence of CVDs, and increasing number of hip and knee replacement surgeries in the region are contributing to the large share of North America.

Report: www.marketsandmarkets.com/speaktoa…m_campaign=PaidPR

The Fluoroscopy Equipment Market in several APAC countries, particularly China, Japan, India, and ASEAN countries, is expected to witness high growth during the forecast period. This can be attributed to the significant growth in the prevalence of CVDs in these countries.

With the growing severity of disease conditions, the demand for fluoroscopy equipment and C-arms in this regional segment is also expected to increase significantly.

The key players in the global Fluoroscopy Equipment Market are Siemens AG  (Germany), GE Healthcare  (US), Koninklijke Philips N.V. (Netherlands), Shimadzu Corporation (Japan), Ziehm Imaging GmbH (Germany), Toshiba Medical Systems Corporation (Japan), Hitachi Ltd.

(Japan), Carestream Health, Inc. (US), Hologic, Inc. (US), Lepu Medical Technology Co., Ltd.

(China), Agfa-Gevaert Group (Belgium), and Adani Systems Inc. (Belarus).

 

News From

MarketsandMarkets™ - Business ResearchMarketsandMarkets™
Category: Market Research Publishers and RetailersCompany profile: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth ...